Accumulating evidence has demonstrated that -glutamyl cyclotransferase (GGCT) exerts potent oncogenic effects across multiple cancer types via the modulation of diverse key signaling pathways
Dihexa is a remarkable peptide originally developed to combat neurodegenerative diseases
References : [1] [3] [4] [5] [6] National Library of Medicine, Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data, Pickart, L., Margolina, A., July 2018 [2] National LIbrary of Medicine, The potential of GHK as an anti-aging peptide, Dou, Y., Lee, A., Zhu, L., Morton, J., Ladiges, W., March 2020
Thus, CPP-CAND is a promising therapeutic candidate with improved selectivity, efficacy, and cost-effectiveness